Skip to main content
KMPHARMACEUTICAL Co.,Ltd. logo

KMPHARMACEUTICAL Co.,Ltd. — Investor Relations & Filings

Ticker · 225430 ISIN · KR7225430008 KO Manufacturing
Open in API
Filings indexed 233 across all filing types
Latest filing 2026-03-31 Board/Management Inform…
Country KR South Korea
Listing KO 225430

About KMPHARMACEUTICAL Co.,Ltd.

https://en.kmkmp.com/

KMPHARMACEUTICAL Co., Ltd. is a company that develops, manufactures, and distributes personal care products. Its core business areas include oral care solutions, such as toothpaste and toothbrushes; beauty and skincare products; and a dedicated line of items for infants and children. The company leverages its research and development expertise to provide Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, creating customized products tailored to client needs in the oral care and cosmetics sectors. It focuses on developing innovative solutions and adheres to strict quality standards, particularly for its children's product lines.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 95% confidence The document is an official announcement of a change in the company’s 대표이사 (CEO). It provides details on the outgoing and incoming CEOs, the date of change, board resolution date, and reasons for the resignation. This fits the definition of a Board/Management Information filing (announcement of changes in senior management).
2026-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is the official Korean ‘주식등의 대량보유상황보고서(일반)’ filing, detailing changes in large shareholdings, reporting threshold crossings by the major shareholder (including dates, quantities, percentages, and related parties). This matches the definition of a Major Shareholding Notification (MRQ).
2026-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a statutory report filed under Korean securities regulations detailing the insider share ownership and transactions of an executive (강일모) at 케이엠제약, including dates, quantities purchased, cumulative holdings, and ownership percentages. This matches the definition of an insider share transaction disclosure (Director’s Dealing).
2026-03-24 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 95% confidence The document is titled “감사보고서” and contains the auditor’s opinion, auditor’s responsibilities, key audit matters, and full audited financial statements (balance sheet, income statement, cash flows, notes). It is a standalone audit report with accompanying financials, not an annual management discussion or earnings release. This matches the definition of an Audit Report / Information (Code: AR). FY 2025
2026-03-23 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy solicitation circular (“의결권 대리행사 권유 참고서류”) detailing how shareholders can exercise or delegate their voting rights ahead of the upcoming shareholder meeting, including agendas, proxy instructions, and voting methods. This aligns exactly with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is titled “감사보고서 제출” (Audit Report Submission) and contains the external auditor’s opinion, audit period, auditor name, and key financial statement figures for the current and prior fiscal years. It is not a full annual report or earnings release but a standalone audit report. Therefore, it fits the Audit Report / Information category. FY 2025
2026-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.